ADAM9 and infection: Similarly, the efficient ADAM9 RNA reduction in stable ADAM9 KD HEK293T cells (44% and 34%) markedly decreased SARS-CoV-2 Spike Vpp infection to 46% and 62% (Fig. S1B and C).